About bioaccess® — The First-in-Human CRO — built for the U.S. and Latin America

bioaccess® was founded in 2010 by Harvard Medical School-trained physician Dr. Pedro Martinez-Clark and renowned interventional cardiologist Dr. William O'Neill. bioaccess® is The First-in-Human CRO — built for the U.S. and Latin America — anchoring on U.S. regulatory strategy (FDA Pre-Sub, IND/IDE) and executing across Latin America. 50+ client companies served since founding.

Company Overview

Legal entity: IMH ASSETS CORP.
Founded: 2010
Headquarters: 1200 Brickell Ave., Suite 1950 #1034, Miami, FL 33131
50+ clients accelerated since founding
50+ pre-qualified clinical trial sites
10 Latin American countries

Leadership

Julio Martinez-Clark — CEO
Dr. Pedro Martinez-Clark, MD — Co-Founder, Chief Medical Officer
Dr. William O'Neill, MD — Co-Founder, Medical Director